Biotecnología
Biotecnología
Human embryo research: how to move towards a 28-day limit
08/07/2025 -
El artículo analiza la propuesta de ampliar el límite actual de cultivo de embriones humanos de 14 a 28 días. Presenta una hoja de ruta que incluye proyectos piloto...
A tissue-specific atlas of protein–protein associations enables prioritization of candidate disease genes
06/05/2025 -
Nature Biotechnology, Published online: 02 May 2025; doi:10.1038/s41587-025-02659-zProtein–protein...
Biotechnology breakthroughs in medicine surge
22/04/2025 -
Biotech breakthroughs are lighting up new ways to care for our health. Researchers are using smart ideas, from gene editing to growing new cells, to make patient care better every day. One cool...
Startup grows egg proteins in potato fields
17/02/2025 -
Nature Biotechnology, Published online: 14 February 2025; doi:10.1038/s41587-025-02563-6Startup grows egg...
Responsible AI in biotechnology: balancing discovery, innovation and biosecurity risks
11/02/2025 -
The integration of artificial intelligence (AI) in protein design presents unparalleled opportunities for innovation in bioengineering and biotechnology. However, it also raises significant...
Advances on transfer and maintenance of large DNA in bacteria, fungi, and mammalian cells
08/01/2025 -
Microbial cell surface display technology, which relies on genetically fusing heterologous target proteins to the cell wall through fusion with cell wall anchor proteins, has emerged as a promising...
Top ten news stories in 2024
10/12/2024 -
Nature Biotechnology, Published online: 04 December 2024; doi:10.1038/s41587-024-02500-zFrom mRNA drugs and the...
2024: research in review
10/12/2024 -
Nature Biotechnology, Published online: 04 December 2024; doi:10.1038/s41587-024-02508-5Nature Biotechnology...
Microbes: next-generation fertilizers
19/08/2024 -
Nature Biotechnology, Published online: 14 August 2024; doi:10.1038/s41587-024-02368-zMicrobes: next-generation...
Orna Therapeutics Acquires ReNAgade Therapeutics
27/05/2024 -
Will combine its circular RNA expression technology with ReNAgade's portfolio of LNP-based RNA delivery systems and editing programs.
Johnson & Johnson Agrees to Acquire Proteologix
27/05/2024 -
Will integrate Proteologix’s bispecific antibodies into its pipeline.
NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
16/05/2024 -
Aim to create opportunities to target previously undruggable disease-causing proteins.
TriLink Invests in New RNA Innovation Center at Johns Hopkins
14/05/2024 -
Will accelerate transformational research in RNA therapeutics and discovery.
Ingenza Secures Innovation Funding to Expand codABLE Gene Design Algorithm
06/05/2024 -
Will adapt its machine learning platform to precisely control recombinant protein expression in Pichia pastoris.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 -
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
02/05/2024 -
Combines MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities.
Fujifilm & Predictive Oncology Tackle Protein Interference
02/05/2024 -
Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
25/04/2024 -
Aim to discover and develop small molecules for the treatment of rare neurological diseases.
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
10/04/2024 -
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Ship of Theseus Taps Charles River as Manufacturing Partner
08/04/2024 -
Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.
